Discovery of the First Thumb Pocket 1 NS5B Polymerase Inhibitor (BILB 1941) with Demonstrated Antiviral Activity in Patients Chronically Infected with Genotype 1 Hepatitis C Virus (HCV) (vol 55, pg 7650, 2012)

被引：0
|
作者：
Beaulieu, Pierre L.
Boes, Michael
Cordingley, Michael G.
Chabot, Catherine
Fazal, Gulrez
Garneau, Michel
Gillard, James R.
Jolicoeur, Eric
LaPlante, Steven
McKercher, Ginette
Poirier, Martin
Poupart, Marc-Andre
Tsantrizos, Youla S.
Duan, Jianmin
Kukolj, George
机构：
来源：
JOURNAL OF MEDICINAL CHEMISTRY | 2014年 / 57卷 / 16期
关键词：
D O I：
10.1021/jm501225c
中图分类号：
R914 [药物化学];
学科分类号：
100701 ;
摘要：
引用
收藏
页码：7144 / 7144
页数：1
相关论文
共 39 条
  • [1] Discovery of the First Thumb Pocket 1 NS5B Polymerase Inhibitor (BILB 1941) with Demonstrated Antiviral Activity in Patients Chronically Infected with Genotype 1 Hepatitis C Virus (HCV)
    Beaulieu, Pierre L.
    Boes, Michael
    Cordingley, Michael G.
    Chabot, Catherine
    Fazal, Gulrez
    Garneau, Michel
    Gillard, James R.
    Jolicoeur, Eric
    LaPlante, Steven
    McKercher, Ginette
    Poirier, Martin
    Poupart, Marc-Andre
    Tsantrizos, Youla S.
    Duan, Jianmin
    Kukolj, George
    JOURNAL OF MEDICINAL CHEMISTRY, 2012, 55 (17) : 7650 - 7666
  • [2] Antiviral Activity of the Hepatitis C Virus Polymerase Inhibitor Filibuvir in Genotype 1 Infected Patients
    Wagner, Frank
    Thompson, Robert
    Kantaridis, Constantino
    Simpson, Paul
    Troke, Philip J. F.
    Jagannatha, Shyla
    Neelakantan, Srividya
    Purohit, Vivek S.
    Hammond, Jennifer L.
    HEPATOLOGY, 2011, 54 (01) : 50 - 59
  • [3] Safety, Tolerability, Pharmacokinetics, and Antiviral Activity of GSK2336805, an Inhibitor of Hepatitis C Virus (HCV) NS5A, in Healthy Subjects and Subjects Chronically Infected with HCV Genotype 1
    Wilfret, D. A.
    Walker, J.
    Adkison, K. K.
    Jones, L. A.
    Lou, Y.
    Gan, J.
    Castellino, S.
    Moseley, C. L.
    Horton, J.
    de Serres, M.
    Culp, A.
    Goljer, I.
    Spreen, W.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (10) : 5037 - 5044
  • [4] SAFETY AND ANTIVIRAL ACTIVITY OF NS5B POLYMERASE INHIBITOR MK-3281, IN TREATMENT-NAiVE GENOTYPE 1A, 1B AND 3 HCV-INFECTED PATIENTS
    Brainard, Diana M.
    Anderson, Matt S.
    Petry, Amelia
    Van Dyck, Kristien
    De Lepeleire, Inge
    Sneddon, Kenneth
    Cummings, Corinne E.
    Nachbar, Robert B.
    Barnard, Richard J.
    Sun, Peng
    Panorchan, Paul
    Sanderson, Joseph B.
    Udezue, Emmanuel
    Wagner, Frank
    Iwamoto, Marian
    Chodakewitz, Jeffrey
    Wagner, John A.
    HEPATOLOGY, 2009, 50 (04) : 1026A - 1027A
  • [5] Discovery of BI 207524, an Indole Diamide NS5B Thumb Pocket 1 Inhibitor with Improved Potency for the Potential Treatment of Chronic Hepatitis C Virus Infection
    Beaulieu, Pierre L.
    Anderson, Paul C.
    Bethell, Richard
    Boes, Michael
    Bousquet, Yves
    Brochu, Christian
    Ley, Michael G. Cording
    Fazal, Gulrez
    Gameau, Michel
    Gillard, James R.
    Kawai, Stephen
    Marquis, Martin
    McKercher, Ginette
    Poupart, Marc-Andre
    Stammers, Timothy
    Thavonekham, Bounkham
    Wernic, Dominik
    Duan, Jianmin
    Kukolj, George
    JOURNAL OF MEDICINAL CHEMISTRY, 2014, 57 (23) : 10130 - 10143
  • [6] Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients
    Aldunate, Fabian
    Echeverria, Natalia
    Chiodi, Daniela
    Lopez, Pablo
    Sanchez-Ciceron, Adriana
    Fajardo, Alvaro
    Sonora, Martin
    Cristina, Juan
    Hernandez, Nelia
    Moreno, Pilar
    DISEASE MARKERS, 2018, 2018
  • [7] Comment on "Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients"
    Eybpoosh, Sana
    Malaie, Mona Kiminezhad
    DISEASE MARKERS, 2018, 2018
  • [8] Randomized, Placebo-Controlled, Single-Ascending-Dose Study of BMS-791325, a Hepatitis C Virus (HCV) NS5B Polymerase Inhibitor, in HCV Genotype 1 Infection
    Sims, Karen D.
    Lemm, Julie
    Eley, Timothy
    Liu, Menping
    Berglind, Anna
    Sherman, Diane
    Lawitz, Eric
    Vutikullird, Apinya B.
    Tebas, Pablo
    Gao, Min
    Pasquinelli, Claudio
    Grasela, Dennis M.
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2014, 58 (06) : 3496 - 3503
  • [9] Response to: Comment on "Pretreatment Hepatitis C Virus NS5A/NS5B Resistance-Associated Substitutions in Genotype 1 Uruguayan Infected Patients"
    Aldunate, Fabian
    Echeverria, Natalia
    Chiodi, Daniela
    Lopez, Pablo
    Sanchez-Ciceron, Adriana
    Fajardo, Alvaro
    Sonora, Martin
    Cristina, Juan
    Hernandez, Nelia
    Moreno, Pilar
    DISEASE MARKERS, 2019, 2019
  • [10] Characterization of NS5A and NS5B Resistance-Associated Substitutions from Genotype 1 Hepatitis C Virus Infected Patients in a Portuguese Cohort
    Brandao, Ruben
    Marcelino, Rute
    Goncalves, Fatima
    Diogo, Isabel
    Carvalho, Ana
    Cabanas, Joaquim
    Costa, Ines
    Brogueira, Pedro
    Ventura, Fernando
    Miranda, Ana
    Mansinho, Kamal
    Gomes, Perpetua
    VIRUSES-BASEL, 2018, 10 (05):
1234